Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Hiring now
1
open roles
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Similar startupsby what they do, their industry and backers

Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for…

Talus Bio makes the regulome—the control layer of gene expression—visible, measuring and modulating gene regulators in live cells to access…

Designer cell therapies for pets first and their people next.

High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.

At Jaguar Gene Therapy, we believe in a world where patients and families won’t have to hear those words. Our mission is to accelerate…

We study the genetic causes of inherited disease to push drug discovery forward with the right targets and predictors of drug response from…
News
NanoVation's ligand-free lcLNP achieves complete B cell depletion in NHP at 0.1 mg/kg
NanoVation's ligand-free lcLNP achieves complete B cell depletion in NHP at 0.1 mg/kg Most lipid nanoparticle (LNP) platforms face the same constraint: they are cleared rapidly by the liver, which makes it hard to deliver nucleic acids to tissues beyond t
Read more
Report
NanoVation wins "Deal of the Year" award from Life Sciences BC
News NanoVation wins "Deal of the Year" award from Life Sciences BC We're thrilled to share that NanoVation Therapeutics has been awarded the prestigious Deal of the Year award at the 27th Annual Life Sciences BC Awards! This recognition celebrates our pa
Read more
Report
NanoVation featured on Biotech TV
News NanoVation featured on Biotech TV NanoVation TherapeuticsTM was recently featured by the online media outlet Biotech TV, which interviewed company co-founders Drs Pieter Cullis and Jay Kulkarni. The host, BiotechTV founder Brad Loncar, opens the disc
Read more
Report
NanoVation Therapeutics: Funding Round Led By Convergent Ventures Completed
NanoVation Therapeutics, a company developing innovative technologies to overcome barriers to nucleic acid delivery, announced the expansion of its Board of Directors and the close of a funding round led by Convergent Ventures.
Read more
Report
NanoVation announces expansion of Board of Directors & completion of funding round led by Convergent Ventures
News NanoVation announces expansion of Board of Directors & completion of funding round led by Convergent Ventures Vancouver, British Columbia - November 19, 2024 -NanoVation Therapeutics, a platform company developing innovative technologies to overcome
Read more
Report
Pro access
Upgrade to see all 13 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Salary insights
Compensation ranges based on this company's open jobs
Median
$91k
Typical range
$91k
Open positions
1
1
Jobs
Middle
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 1 | $91k | $91k |
Highest paying role
Scientist III, Preclinical-12 month contract
$91k
Normalized to USD per year
Growth
Hiring Momentum
48/100
Stable
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~20 hours
09/26/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
100% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Vancouver
Vancouver
Canada
HQ
2 open roles 50% engineering 10-50 est. staff $91k Avg Salary
hires for Science & Research, Early Careers
